我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的隐私政策。
相关临床试验
78
13 进行中
药物批准
0
批准总数
监管机构
监管机构数
成立时间
2001
进行中（未招募）
9
11.5%
已完成
43
55.1%
尚未招募
4
5.1%
招募中
13
16.7%
暂停
1
1.3%
终止
6
7.7%
撤回
2
2.6%
暂无批准数据
- A randomized controlled trial of 360 children aged 5-15 found that a budesonide-formoterol combination inhaler reduced asthma attacks by 45% compared to standard salbutamol treatment. - The CARE study demonstrated that switching 100 children from salbutamol to the 2-in-1 inhaler would prevent 18 asthma attacks per year with no safety concerns. - Published in The Lancet, these findings could align pediatric asthma guidelines with adult treatment standards, potentially benefiting millions of children worldwide with mild-to-moderate asthma.
